Cargando…
FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer
BACKGROUND: Early prediction of response to neoadjuvant chemotherapy (NAC) is critical in choosing appropriate chemotherapeutic regimen for patients with locally advanced breast cancer. Herein, we sought to identify potential biomarkers to predict the response to neoadjuvant chemotherapy for breast...
Autores principales: | Xie, Qin, Xiao, Ying-sheng, Jia, Shi-cheng, Zheng, Jie-xuan, Du, Zhen-chao, Chen, Yi-chun, Chen, Mu-tong, Liang, Yuan-ke, Lin, Hao-yu, Zeng, De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684949/ https://www.ncbi.nlm.nih.gov/pubmed/33292226 http://dx.doi.org/10.1186/s12935-020-01656-3 |
Ejemplares similares
-
FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer
por: Li, Guoqing, et al.
Publicado: (2021) -
Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway
por: Pan, Jiaomeng, et al.
Publicado: (2019) -
FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport
por: Tian, Wenying, et al.
Publicado: (2020) -
Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
por: Wu, Ziping, et al.
Publicado: (2019) -
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
por: Le, Yong, et al.
Publicado: (2019)